Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis.
Calandriello L, De Lorenzis E, Cicchetti G, D'Abronzo R, Infante A, Castaldo F, Del Ciello A, Farchione A, Gremese E, Marano R, Natale L, D'Agostino MA, Bosello SL, Larici AR. Calandriello L, et al. Tomography. 2023 May 11;9(3):981-994. doi: 10.3390/tomography9030080. Tomography. 2023. PMID: 37218940 Free PMC article.
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.
De Lorenzis E, Parente P, Natalello G, Soldati S, Bosello SL, Barbara A, Sorge C, Axelrod S, Verardi L, Cerasuolo PG, Peluso G, Gemma A, Davoli M, Biliotti D, Bruzzese V, Goletti M, Di Martino M, D'Agostino MA. De Lorenzis E, et al. Joint Bone Spine. 2023 Mar;90(2):105497. doi: 10.1016/j.jbspin.2022.105497. Epub 2022 Nov 21. Joint Bone Spine. 2023. PMID: 36423782 Free PMC article. No abstract available.
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists.
D'Angelo S, Atzeni F, Benucci M, Bianchi G, Cantini F, Caporali RF, Carlino G, Caso F, Cauli A, Ciccia F, D'Agostino MA, Dagna L, Dejaco C, Epis OM, Ferrucci MG, Franceschini F, Fusaro E, Gabini M, Gerli R, Giacomelli R, Govoni M, Gremese E, Guggino G, Iagnocco A, Iannone F, Laganà B, Lubrano E, Montecucco C, Peluso R, Ramonda R, Rossini M, Salvarani C, Sebastiani GD, Sebastiani M, Selmi C, Tirri E, Marchesoni A. D'Angelo S, et al. Front Med (Lausanne). 2023 Nov 30;10:1327931. doi: 10.3389/fmed.2023.1327931. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38098852 Free PMC article.
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Solitano V, Facheris P, Petersen M, D'Amico F, Ortoncelli M, Aletaha D, Olivera PA, Bieber T, Ramiro S, Ghosh S, D'Agostino MA, Siegmund B, Chary-Valckenaere I, Hart A, Dagna L, Magro F, Felten R, Kotze PG, Jairath V, Costanzo A, Kristensen LE, Biroulet LP, Danese S. Solitano V, et al. Autoimmun Rev. 2023 Dec 20;23(3):103504. doi: 10.1016/j.autrev.2023.103504. Online ahead of print. Autoimmun Rev. 2023. PMID: 38128748 Review.
Reply.
Collado P, Naredo E, D'Agostino MA. Collado P, et al. Arthritis Care Res (Hoboken). 2023 Dec;75(12):2545. doi: 10.1002/acr.25198. Epub 2023 Aug 7. Arthritis Care Res (Hoboken). 2023. PMID: 37458137 No abstract available.
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Cope AP, Jasenecova M, Vasconcelos JC, Filer A, Raza K, Qureshi S, D'Agostino MA, McInnes IB, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga T, Toes R, Georgiou E, Kelly J, Murphy C, Prevost AT; APIPPRA study investigators. Cope AP, et al. Among authors: d agostino ma. Lancet. 2024 Mar 2;403(10429):838-849. doi: 10.1016/S0140-6736(23)02649-1. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364839 Free article. Clinical Trial.
265 results